Discover 482 paid clinical trials in Rhode Island. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Rhode Island offers a variety of research opportunities for healthy individuals looking to volunteer in paid studies and those with specific health conditions alike. Research centers in Providence, Warwick, and Cranston are actively recruiting participants, providing access to advanced treatments and top-tier healthcare.
Filter
1
Filter results
Results: 482
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
Irrisept Solution for Instrumented Spine Surgery
for
Post-Op Complication, Spine Surgery, Site Infection,
Location: Providence RI
Sponsor: Rhode Island Hospital
Sex: All
Age: 18+
Code: NCT06439953
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Location: Boston MA, Providence RI, Westerly RI, Waterford CT,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Sex: All
Age: 18+
Code: NCT04031677
Phase3, Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
for
Post Operative Surgical Site Infection
Location: Boston MA, Providence RI, Lebanon NH, Jamaica NY,
Sponsor: Major Extremity Trauma Research Consortium
Sex: All
Age: 18 - 64
Code: NCT04678154
Phase3, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Scarborough ME, South Weymouth MA, Boston MA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
for
Alzheimer Disease, Early Onset, Mild Cognitive Impairment,
Location: Providence RI, Los Angeles CA
Sponsor: Butler Hospital
Sex: All
Age: 50 - 70+
Code: NCT04500847
Phase1, Recruiting
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Location: Boston MA, Providence RI, Decatur GA, Omaha NE,
Sponsor: VA Office of Research and Development
Sex: All
Age: 35 - 70+
Code: NCT05937854
Phase2, Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
for
Crohn's Disease
Location: Providence RI, Hamden CT, New York NY, Montreal,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06045754
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer